UNICA IRIS Institutional Research Information System

DEPLANO, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 76.848
NA - Nord America 2.829
AS - Asia 1.377
SA - Sud America 304
AF - Africa 63
OC - Oceania 24
Totale 81.445
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 76.084
US - Stati Uniti d'America 2.779
SG - Singapore 579
CN - Cina 383
BR - Brasile 236
SE - Svezia 176
VN - Vietnam 140
UA - Ucraina 136
DE - Germania 92
FR - Francia 75
GB - Regno Unito 73
FI - Finlandia 66
ES - Italia 49
IN - India 46
HK - Hong Kong 42
CA - Canada 33
BD - Bangladesh 28
AR - Argentina 27
AU - Australia 23
PK - Pakistan 21
IQ - Iraq 20
MA - Marocco 16
PL - Polonia 16
RU - Federazione Russa 16
JP - Giappone 15
BE - Belgio 14
EC - Ecuador 14
EG - Egitto 14
ZA - Sudafrica 14
KR - Corea 13
MX - Messico 12
VE - Venezuela 12
ID - Indonesia 11
NL - Olanda 10
TR - Turchia 10
TW - Taiwan 9
AT - Austria 7
AZ - Azerbaigian 7
CO - Colombia 7
PT - Portogallo 7
DZ - Algeria 6
PH - Filippine 6
UZ - Uzbekistan 6
HU - Ungheria 5
JO - Giordania 5
IR - Iran 4
LT - Lituania 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
IE - Irlanda 3
IL - Israele 3
KE - Kenya 3
KZ - Kazakistan 3
NG - Nigeria 3
NP - Nepal 3
OM - Oman 3
PE - Perù 3
RO - Romania 3
CL - Cile 2
HR - Croazia 2
LB - Libano 2
MY - Malesia 2
PY - Paraguay 2
SA - Arabia Saudita 2
TH - Thailandia 2
TN - Tunisia 2
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
LY - Libia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
RE - Reunion 1
RS - Serbia 1
SV - El Salvador 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
Totale 81.445
Salva come PNG Salva come JPEG
Città #
Cagliari 74.641
Uta 1.263
Ashburn 346
Singapore 317
Fairfield 204
Chandler 188
Woodbridge 171
San Jose 139
Dallas 138
Wilmington 120
Nyköping 112
Houston 106
Ann Arbor 104
Boardman 103
Seattle 93
Beijing 72
Cambridge 70
Dearborn 63
Jacksonville 62
Los Angeles 52
Santa Clara 51
Shanghai 47
Council Bluffs 42
Helsinki 36
Ho Chi Minh City 32
Hanoi 31
São Paulo 30
Nanjing 29
Boston 28
Dong Ket 28
Lauterbourg 28
San Diego 28
New York 27
Hong Kong 26
Buffalo 22
Chicago 22
Barcelona 21
Washington 21
The Dalles 19
Frankfurt am Main 17
Canberra 15
Hefei 15
Munich 15
Redwood City 14
Guangzhou 13
Orem 13
Perugia 13
Sassari 13
Toronto 13
Casablanca 12
Jiaxing 11
Nanchang 11
Tokyo 11
Brooklyn 10
Brussels 10
Hyderabad 10
Johannesburg 10
Milan 10
Tianjin 10
Turku 10
Paris 9
Phoenix 9
Seoul 9
Atlanta 8
Central 8
Changsha 8
Chapel Hill 8
Hebei 8
Madrid 8
Messina 8
Mountain View 8
Olbia 8
Champaign 7
Dhaka 7
Ferrara 7
London 7
Tappahannock 7
Baku 6
Belo Horizonte 6
Brunswick 6
Cairo 6
Maia 6
Nuremberg 6
Ottawa 6
Quartu Sant'elena 6
Quito 6
San Mateo 6
Shenyang 6
Sydney 6
Warsaw 6
Amman 5
Amsterdam 5
Baghdad 5
Basingstoke 5
Biên Hòa 5
Budapest 5
Columbus 5
Denver 5
Falls Church 5
Fortaleza 5
Totale 79.450
Salva come PNG Salva come JPEG
Nome #
In vitro nematicidal activity of aryl hydrazones and comparative GC-MS metabolomics analysis 12.060
Novel propanamides as fatty acid amide hydrolase inhibitors 5.075
Potent nematicidal activity of maleimide derivatives on Meloidogyne incognita 3.892
Design, synthesis and antiviral evaluation of novel heteroarylcarbothioamide derivatives as dual inhibitors of HIV-1 Reverse transcriptase-associated RNase H and RDDP functions 3.514
Design, synthesis and evaluation of antiproliferative activity of new benzimidazolehydrazones 2.905
Inhibitory effect of positively charged triazine antagonists of prokinecitin receptors on the transient receptor vanilloid type-1 (TRPV1) channel 2.855
Dihydroquinazoline and Triazinedione Derivatives as Prok1 and Prok2 receptor antagonists in HEK-293 transfected cells 2.730
Synthesis and carbonic anhydrase I, II, IX and XII inhibitory activity of sulfamates incorporating piperazinyl-ureido moieties 2.707
DIHYDROQUINAZOLINE BENZYLAMIDES AS ACETYLCHOLINESTERASE AND BUTYRYLCHOLINESTERASE INHIBITORS 2.599
A new convenient synthetic method and preliminary pharmacological characterization of triazinediones as prokineticin receptor antagonists 2.597
DESIGN, SYNTHESIS AND PHARMACOLOGICAL INVESTIGATION OF NEW DNA METHYLTRANSFERASE INHIBITORS 2.584
Interaction of the N-(3-Methylpyridin-2-yl)amide derivatives of flurbiprofen and ibuprofen with FAAH: Enantiomeric selectivity and binding mode 2.541
Synthesis of sulfonamides incorporating piperazinyl-ureido moieties and their carbonic anhydrase I, II, IX and XII inhibitory activity 2.367
Characterisation of (R)-2-(2-Fluorobiphenyl-4-yl)-N-(3-Methylpyridin-2-yl)Propanamide as a Dual Fatty Acid Amide Hydrolase: Cyclooxygenase Inhibitor 2.353
Halogenated triazinediones behave as antagonists of PKR1: in vitro and in vivo pharmacological characterization 2.249
Structure-activity relationship with pyrazoline-based aromatic sulfamates as carbonic anhydrase isoforms I, II, IX and XII inhibitors: Synthesis and biological evaluation 2.202
Investigation of the mechanism of FAAH inhibition of profen amide derivatives 2.119
Benzylamides and piperazinoarylamides of ibuprofen as fatty acid amide hydrolase inhibitors 1.800
null 1.768
Appliance of the piperidinyl-hydrazidoureido linker to benzenesulfonamide compounds: Synthesis, in vitro and in silico evaluation of potent carbonic anhydrase II, IX and XII inhibitors 1.768
null 1.650
Discovery of a novel class of profen derivatives as FAAH inhibitors: MD and QM/MM studies of the binding mode and 3D SAR 1.593
Sulfonamide/sulfamate switch with a series of piperazinylureido derivatives: Synthesis, kinetic and in silico evaluation as carbonic anhydrase isoforms I, II, IV, and IX inhibitors 1.516
Exploring the fatty acid amide hydrolase and cyclooxygenase inhibitory properties of novel amide derivatives of ibuprofen 1.466
null 1.383
Synthesis and in vitro evaluation of piperazinyl-ureido sulfamates as steroid sulfatase inhibitors 1.327
The fatty acid amide hydrolase and cyclooxygenase-inhibitory properties of novel amide derivatives of carprofen 1.298
Design, synthesis and SAR of small molecules acting on pain pathways 1.269
Design, synthesis and in vitro and in vivo biological evaluation of flurbiprofen amides as new fatty acid amide hydrolase/cyclooxygenase-2 dual inhibitory potential analgesic agents 1.115
Molecular Basis for Non-Covalent, Non-Competitive FAAH Inhibition 1.020
Homology modeling of a Class A GPCR in the inactive conformation: A quantitative analysis of the correlation between model/template sequence identity and model accuracy 951
Development and Validation of Molecular Overlays Derived from Three-Dimensional Hydrophobic Similarity with PharmScreen 863
Hydrophobic similarity between molecules: Application to three-dimensional molecular overlays with PharmScreen 832
Design, Synthesis and Evaluation of new 2-(Arylidenehydrazino)pyrrole Derivatives as Potential Antitumor Agents 807
Onthe use (QM) IEF/PMC-MST-derived hydrophobic contributions as physicochemical descriptors in 3D-QSAR: the PHARMSQSARTM approach 780
Synthesis of Sulfonamides Incorporating Piperidinyl-Hydrazidoureido and Piperidinyl-Hydrazidothioureido Moieties and Their Carbonic Anhydrase I, II, IX and XII Inhibitory Activity 679
Design, synthesis and pharmacological investigation on new FAAH inhibitors 422
Totale 81.656
Salva come PNG Salva come JPEG
Categoria #
all - tutte 96.460
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.460
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.631 0 0 0 0 0 0 0 0 0 934 1.201 496
2021/20223.774 311 314 368 120 283 309 385 253 179 335 401 516
2022/20235.447 564 702 498 462 474 592 288 339 298 304 476 450
2023/20245.404 225 184 190 309 484 795 849 348 333 355 668 664
2024/202518.705 1.807 4.639 1.151 8.585 827 647 634 61 147 60 77 70
2025/20262.404 231 116 275 272 209 198 325 214 185 379 0 0
Totale 81.656